The exact timing of the symptoms depends on your exposure to an allergen – the thing you’re allergic to. Here’s how to work ...

If you’ve experienced a fullness in your ears that makes you feel as if you’re on a plane 30,000 feet in the air when you’re ...

There are several options that can help you stop snoring. One of these is a simple and tasty ‘superfood’ that may help reduce ...

Persistence in war matters, often in unexpected ways, validating Carl von Clausewitz’s axiom that “no other human activity is ...

The researchers also discovered that when tested on mice, a single dose of PCANS nasal spray blocked infection from the ...

"I know it can be disheartening to wake up and find a new ailment every so often, but the alternative is to remain perfectly ...

"I've had these since my childhood and never had a nostril it couldn't set right. I'm surprised these aren't more common in ...

Meehan, 60, experienced a medical emergency due to a blockage in his bowel, he said in a video posted to social media.

GSK announced positive results from two phase 3 clinical trials evaluating its experimental drug, depemokimab, for chronic rhinosinusitis with nasal polyps affecting 4% of the population.

The company has set high expectations for depemokimab, which it is also advancing in three other inflammatory diseases, including asthma.

GSK's depemokimab met key endpoints in phase 3 trials for chronic rhinosinusitis with nasal polyps (CRSwNP), showing promise ...